OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/30/2025
Back to search
Official data from USPTO
BIONTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079353523Class
1, 5, 9, 10, 35, 42, 44
Filing
79353523
Registration
7166547
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
12/01/2025
Trademark type
Combined
Nice classes
1, 5, 9, 10, 35, 42, 44
Filing date
12/28/2021
Registration date
09/19/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/19/2023
Last transaction
12/01/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
DE
Examiner
REGAN,JOHN B
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of stylized letters reading "BIONTECH" wherein the "B", "I", "O", "E", "C" and "H" appear in dark green color and the "N" and "T" appear in light green color.
Holders and representatives
Holders
B. S. (pessoa física)
Representatives
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in pharmaceutical industry; active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines; adjuvants for use in manufacture of vaccines; nucleic acidsproteins and peptides for laboratory use; diagnostic preparations for scientific or research use other than for medical purposes
Class 5
Pharmaceutical products for the prevention and treatment of cancerinfectious diseasesimmunological diseasesexcept vitamin preparationsmineral food supplementsprobioticsomega 3 preparationsdietetic substances and food supplements for medical and non-medical purposes; Vaccines; Chemical reagents used for medical purposes; Biochemical reagents used for purposes for the treatment of cancertreatment of immunological diseasestreatment of infectious diseases; Macromoleculesnucleic acid sequences and proteinsused for medical and veterinary purposes; cell based immune therapeutics for treatment of cancertreatment of immunological diseasestreatment of infectious diseases; diagnostic preparations for clinical or medical laboratory use
Class 9
Downloadable mobile applications for enabling healthcare professionals and patients to access information on pharmaceuticalmedical and vaccine products and services; downloadable computer software for enabling healthcare professionals and patients to access information on pharmaceuticalmedical and vaccine products and services; downloadable e-commerce computer software for enabling users to perform electronic business transactions via a global computer network
Class 10
Medical diagnostic devices for analysis of body fluids and biopsies for diagnosis and monitoring of cancerinfectious diseasesimmunological diseases; medical diagnostic devices for analysis of body fluids and biopsies for patient stratification
Class 35
Business advisory services in the field of electronic commerce; providing business information in the field of electronic commerce; providing business informationcustomer information on pharmaceutical and medical products through an on-line computer network; wholesale and retail store services featuring pharmaceutical productsmedicinal preparationsmedical supplies
Class 42
medical and scientific research in the field of treatment of immunological diseasescancer treatmenttreatment of infectious diseases; providing medical and scientific research informationconsultancyadvisory servicesall in the fields of medical and scientific research in the field of treatment of immunological diseasescancer treatmenttreatment of infectious diseases; medical and scientific research services by compiling data for clinical trials and drug admission
Class 44
Medicalhygienic and beauty care; healthcare services; provision of medical information and services; provision of medical information to patients and healthcare professionals concerning pharmaceutical productsvaccinesmedical productsmedical diseases and disorders and related treatments via the Internet; medical services in the field of gene therapy; medical services in the field of cell therapy; medical and health care services; medical servicesproviding therapies for treating cancerinfectious diseases and immunological diseases; veterinary servicesproviding therapies for treating cancerinfectious diseasesimmunological diseases; medical and pharmaceutical consultation; medical diagnostic testingmonitoring and reporting services; genetic testing for medical purposes
Publications
History of USPTO decisions and trademark events.
39 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/12/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/12/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/31/2025
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
08/26/2024
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
06/17/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/08/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/21/2023
FIMP
FINAL DISPOSITION PROCESSED
12/21/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/19/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/25/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/25/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/25/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/19/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
09/19/2023
GPNX
NOTIFICATION PROCESSED BY IB
07/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/04/2023
PUBO
PUBLISHED FOR OPPOSITION
07/04/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/21/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/20/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/14/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/26/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
05/03/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/03/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
05/03/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/31/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/31/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/31/2023
RFNT
REFUSAL PROCESSED BY IB
02/15/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/20/2023
RFRR
REFUSAL PROCESSED BY MPU
01/20/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/15/2022
CNRT
NON-FINAL ACTION WRITTEN
11/14/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/11/2022
DOCK
ASSIGNED TO EXAMINER
11/07/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/01/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/27/2022
Continuous trademark protection
Get notified about every new filing that threatens BIONTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.